RAPT Therapeutics, Inc. (RAPT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.1400 |
| Open | 4.2300 |
| Bid | 4.0200 x 300 |
| Ask | 4.0600 x 400 |
| Day's range | 4.0300 - 4.2322 |
| 52-week range | 3.9800 - 27.3500 |
| Volume | |
| Avg. volume | 1,542,114 |
| Market cap | 141.01M |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
The heavy selling pressure might have exhausted for Rapt Therapeutics (RAPT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Simply Wall St.
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
Insights into RAPT Therapeutics' Financial Performance and Strategic Decisions Amidst Clinical Trials
© 2024 Yahoo. All rights reserved.